Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Filings indexed 486 across all filing types
Latest filing 2023-04-20 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Nexturn Bio regarding the exercise of conversion rights for convertible bonds (전환청구권행사). It details the conversion of debt into equity, including the number of shares, conversion price, and the impact on total shares outstanding. This type of filing relates to changes in capital structure and share issuance resulting from debt conversion, which falls under the 'Share Issue/Capital Change' category.
2023-04-20 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Nexturn Bio) detailing the exercise of conversion rights (전환청구권행사) for convertible bonds into common shares. This involves a change in the company's capital structure through the issuance of new shares resulting from bond conversion. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2023-04-20 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Nexturn Bio regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which falls under capital changes. According to the provided categories, 'SHA' (Share Issue/Capital Change) is the most appropriate classification for announcements regarding new share issues or capital structure changes resulting from bond conversions.
2023-04-12 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Nexturn Bio regarding the exercise of conversion rights (convertible bonds into shares). It details the number of shares to be issued, the conversion price, and the remaining balance of convertible bonds. This type of filing relates to capital structure changes and the issuance of new shares resulting from debt conversion, which falls under the 'Share Issue/Capital Change' category.
2023-04-12 Korean
[기재정정]주식병합결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Nexturn Bio regarding a 'Stock Consolidation Decision' (주식병합결정). It details the amendment of a previous filing concerning the consolidation of shares, including changes to the total number of shares and the effective dates. Since this relates to a change in capital structure (share consolidation) rather than a simple share issuance or buyback, it falls under the 'Share Issue/Capital Change' category.
2023-04-12 Korean
[기재정정]주식병합결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Nexturn Bio) regarding a 'Stock Consolidation Decision' (주식병합결정). It details the amendment of a previous filing due to changes in the total number of shares following the exercise of conversion rights. Since this document describes a change in capital structure (stock consolidation/reverse split) rather than a simple share issuance or buyback, and it is a formal regulatory disclosure, it falls under the 'Share Issue/Capital Change' category.
2023-04-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.